Table 1.
Prevalence of anti-Toxoplasma gondii and anti-Brucella spp. antibodies in pregnant women from Mogadishu, Somalia.
| Variable | LAT | RBPT | cELISA | ||||||
|---|---|---|---|---|---|---|---|---|---|
| +/n | Prevalence (%) (95% CI) | P-value | OR (95% CI) | +/n | Prevalence (%) (95% CI) | +/n | Prevalence (%) (95% CI) | ||
| Age | 15–30* | 132/262 | 50.38 (44.37–56.39) | 1/262 | 0.38 (0.00–2.35) | 2/262 | 0.76 (0.03–2.9) | ||
| 31–40 | 25/42 | 59.52 (44.47–72.98) | 0.272 (χ2 = 1.2) | 1.4 (0.7–2.8) | 1/42 | 2.38 (0.00–13.44) | 1/42 | 2.38 (0.00–13.44) | |
| >40 | 2/3 | 66.67 (20.25–94.37) | 0.575 (χ2 = 0.3) | 2 (0.2–22) | 0/3 | 0.00 | 0/3 | 0.00 | |
| Gestational age | 1st trimester | 24/44 | 54.55 (40.06–68.3) | 0.507 (χ2 = 0.4) | 1.2 (0.6–2.4) | 0/44 | 0.00 | 0/44 | 0.00 |
| 2nd trimester | 32/53 | 60.38 (46.92–72.43) | 0.140 (χ2 = 2.2) | 1.6 (0.9–2.9) | 0/53 | 0.00 | 0/53 | 0.00 | |
| 3rd trimester* | 103/210 | 49.05 (42.36–55.76) | 2/210 | 0.95 (0.03–3.59) | 3/210 | 1.43 (0.29–4.25) | |||
| History of abortion | Yes | 64/119 | 53.78 (44.85–62.48) | 0.579 (χ2 = 0.3) | 1.1 (0.7–1.8) | 2/119 | 1.68 (0.08–6.2) | 3/119 | 2.52 (0.52–7.29) |
| No* | 95/188 | 50.53 (43.45–57.6) | 0/188 | 0.00 | 0/188 | 0.00 | |||
*
Reference, +, number of positive samples; n, number of samples; 95% CI, 95% confidence interval; OR, odds ratio.